Last updated 2026-07-20
Total raised
—
Last: Grant 2020-01
Stage
Pre-Funding
Founded
2018
Headcount
—
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences
About
Crispr Stem & Therapeutics Ltd is an Israel-based startup company developing a patented Cardio-Protective CRISPR-based stem cell protocol to restrict damage to the heart following an acute heart attack. Their technology genetically modifies a patient's own stem cells using CRISPR, which are then treated and implanted into the acute ischemic heart patient. The protocol has shown dramatically decreased heart damage in in vitro and in vivo animal models. The company is seeking investors to complete the pre-clinical phase and GMP protocol (kit).
Offices
Petah Tikva, Israel · HQ / main office
Q&A
- What is Crispr Stem & Therapeutics (CST) developing?
- Crispr Stem & Therapeutics (CST) is developing a patented cardio-protective CRISPR-based stem cell protocol to restrict heart damage following acute heart attack and chronic heart failure.
- When was Crispr Stem & Therapeutics (CST) founded?
- Crispr Stem & Therapeutics (CST) was founded in May 2018.
- How many employees does Crispr Stem & Therapeutics (CST) have?
- Crispr Stem & Therapeutics (CST) has 1-10 employees.
- What was Crispr Stem & Therapeutics (CST)'s last funding round?
- Crispr Stem & Therapeutics (CST) received a Grant round in January 2020, with the Israel Innovation Authority as a lead investor.
- What is the total amount of funding Crispr Stem & Therapeutics (CST) has raised?
- Crispr Stem & Therapeutics (CST) has raised a total of $100,000 USD.
- Where is Crispr Stem & Therapeutics (CST) headquartered?
- Crispr Stem & Therapeutics (CST) is headquartered in Petah Tikva, Israel.
- Who is the Founder & CEO of Crispr Stem & Therapeutics (CST)?
- Dr. Dalia El-Ani is the Founder & CEO of Crispr Stem & Therapeutics (CST).
- Has Crispr Stem & Therapeutics (CST) received any notable recognition?
- Crispr Stem & Therapeutics (CST) received recognition from the Israeli Innovation Authority (Tnufa funding) and two Seals of Excellence from the European Commission.
Team · 6
Dr. Dalia El-Ani
Founder · Founder, CEO and Chief Scientist
Dr. David Kain
Cardio Scientific Consultant
Reuven Ulmansky
CFO & VP Business Development
Dr. Raziel Hamami
Expert in Tissue Engineering, Stem Cell Therapy for ischemic heart
Dr. Ronald Ellis
Business Consultant
Prof. Reuven Zimlichman
Advisor
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCellsGenes
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesBiotechnology
Business model
B2B
Highlights
1 PatentsVerified
Tags
ischemiatherapeuticscardiovascularheart-failurecell-therapymedical-technologiesstem-cellstissue-regeneration
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | crisprstemtherapeutics.com/ |
|---|---|
| linkedin.com/company/74934002 |
Identifiers & details
| Legal name | Crispr Stem & Therapeutics Ltd |
|---|---|
| Former names | CRISPR THERAPEUTICS |
| Founded | 2018-5 |
Radar intelligence
Web history (Wayback)
| Domain | crisprstemtherapeutics.com |
|---|
Certificate / subdomain footprint
| Subdomains | 9 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515840445 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2018-05-03 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 2 — annual_report (1), violation (1) |
| Registered address | דב שילנסקי 28 פתח תקווה |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-25 | דו~ח שנתי-עדכון מען דיגיטלי |
| 2026-06-25 | עדכון הפרה |